Huakang Biomedical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
Huakang Biomedical Holdings Company Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 5.9 million compared to CNY 4.89 million a year ago. Net loss was CNY 0.681 million compared to CNY 1.15 million a year ago. Basic loss per share from continuing operations was CNY 0.0017 compared to CNY 0.0029 a year ago.